Follow Us TR

News Details

Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine

About Novavax, Inc.
  • NASDAQ: $NVAX
  • Notified: $46.03
  • 16:30 EDT

Price Chart